Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a novel therapy for the treatment of hypervascuarized tumours. Through the intra-arterial delivery of microspheres, DEB-TACE allows for embolization as well as local release of chemotherapy in the treatment of hepatic malignancy, providing an alternative therapeutic option in unresectable tumours. Drug-eluting bead TACE is becoming more widely utilized in primary and liver-dominant metastatic disease of the liver. Microcatheters, are thin wall, small diameter catheters and delivery devices used in minimally invasive applications. These small catheters are ideal for navigating the vast network of tiny veins found within the body. Microcatheters are employed extensively in the neurovascular and cardiovascular fields. They are most commonly used in small vessel or selective diagnostic and interventional procedures, where an application requires an ultra-thin device for delivery, diagnosis, or mapping, a microcatheter is used. Radiopaque beads provide a practical solution for real time display of embolic material or drug delivery. These beads provide better conspicuity in determining the target during embolization and also allow optimal balance and delivery performance.
The global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market report estimates the market size (Revenue USD million – 2014 to 2021) by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World and forecasts growth trends (CAGR% – 2017 to 2021). The global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating the global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market and profiled in this report include Abbott Laboratories (Abbott EP), ABK Biomedical, Inc., Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Medtronic, Inc., Merit Medical Systems, Inc., Stryker Corporation, Surefire Medical, Inc., Terumo Corporation, and Vascular Solutions, Inc.